Flowise Capsule
Flowise Capsule : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL25126123T
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- ACE HEALTH PRODUCTS SDN. BHD.
- Manufacturer
- ACE HEALTH PRODUCTS SDN. BHD.
- Registration date
- 2025-12-04
- Published validity end
- 2030-12-04
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Glycine max. (L.) Merr.: La portion journalière recommandée ne doit pas conduire à une ingestion d'isoflavones supérieure à 1 mg/kg de poids corporel (exprimés comme aglycone du composant principal). L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Contains red yeast rice. Monacolins must remain below 3 mg per daily portion, with mandatory warnings on the label. The monacolin content is not declared in Compl'Alim.
annexe III, partie B (règlement (UE) 2022/860). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Mangifera indica | Mangifera indica[100 mg,480 mg] | Not identified |
| Glycine max | Glycine max[100 mg,480 mg] | Not identified |
| Monascus purpureus | Monascus purpureus[200 mg,480 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Mangifera indica[100 mg,480 mg],Glycine max[100 mg,480 mg],Monascus purpureus[200 mg,480 mg]
- Valid until
- 2030-12-04
- Registration date
- 2025-12-04
- Published description
- NATURAL PRODUCT
- Licence holder
- ACE HEALTH PRODUCTS SDN. BHD.
- Producer
- ACE HEALTH PRODUCTS SDN. BHD.
- Published name
- Flowise Capsule
- Published reference
- 2025071619315T
- Registration number
- MAL25126123T
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL25126123T
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.